1. Home
  2. MOGO vs UBX Comparison

MOGO vs UBX Comparison

Compare MOGO & UBX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MOGO
  • UBX
  • Stock Information
  • Founded
  • MOGO 2003
  • UBX 2009
  • Country
  • MOGO Canada
  • UBX United States
  • Employees
  • MOGO N/A
  • UBX N/A
  • Industry
  • MOGO
  • UBX Biotechnology: Pharmaceutical Preparations
  • Sector
  • MOGO
  • UBX Health Care
  • Exchange
  • MOGO Nasdaq
  • UBX Nasdaq
  • Market Cap
  • MOGO 32.5M
  • UBX 36.9M
  • IPO Year
  • MOGO N/A
  • UBX 2018
  • Fundamental
  • Price
  • MOGO $1.15
  • UBX $1.94
  • Analyst Decision
  • MOGO Strong Buy
  • UBX Strong Buy
  • Analyst Count
  • MOGO 1
  • UBX 2
  • Target Price
  • MOGO $6.00
  • UBX $7.00
  • AVG Volume (30 Days)
  • MOGO 56.7K
  • UBX 203.3K
  • Earning Date
  • MOGO 03-19-2025
  • UBX 04-14-2025
  • Dividend Yield
  • MOGO N/A
  • UBX N/A
  • EPS Growth
  • MOGO N/A
  • UBX N/A
  • EPS
  • MOGO N/A
  • UBX N/A
  • Revenue
  • MOGO $30,995,226.00
  • UBX N/A
  • Revenue This Year
  • MOGO N/A
  • UBX N/A
  • Revenue Next Year
  • MOGO $3.73
  • UBX $33.62
  • P/E Ratio
  • MOGO N/A
  • UBX N/A
  • Revenue Growth
  • MOGO N/A
  • UBX N/A
  • 52 Week Low
  • MOGO $0.94
  • UBX $0.94
  • 52 Week High
  • MOGO $2.25
  • UBX $3.10
  • Technical
  • Relative Strength Index (RSI)
  • MOGO 36.67
  • UBX 48.69
  • Support Level
  • MOGO $1.14
  • UBX $1.99
  • Resistance Level
  • MOGO $1.22
  • UBX $2.17
  • Average True Range (ATR)
  • MOGO 0.07
  • UBX 0.22
  • MACD
  • MOGO -0.01
  • UBX -0.05
  • Stochastic Oscillator
  • MOGO 4.88
  • UBX 22.41

About MOGO Mogo Inc.

Mogo Inc is a Canadian-based financial technology company. It offers a finance application to consumers with solutions that help them to control their financial health. At Mogo, users can sign up for a free account and get access to products and solutions that help users to monitor their credit score, protect themselves from identity fraud, control their spending, and borrow responsibly. Company offers digital loans and mortgages and also offer a digital payments platform that powers next-generation card programs for both established global corporations and innovative fintech companies in Europe and Canada.

About UBX Unity Biotechnology Inc.

Unity Biotechnology Inc designs therapeutics that prevent, halt, and reverse various diseases of aging. The company focuses on clearing senescent cells, and creating senolytic medicines. Its medicines target vulnerabilities unique to senescent cells to clear those cells from the human body while leaving normal cells unaffected. The firm focuses on age-associated diseases such as osteoarthritis, eye diseases, and pulmonary diseases. Its drug candidates include, UBX1325 is being developed for age-related diseases of the eye, including diabetic macular edema, or DME, UBX2089, which is a circulating hormone primarily produced in the kidneys and choroid plexus of the brain, which is being researched for multiple neurology indications, and UBX2050.

Share on Social Networks: